688575.SS SHH
Shenzhen YHLO Biotech Co., Ltd.
1W: +0.9%
1M: +2.5%
3M: +14.8%
YTD: -22.9%
1Y: -33.1%
3Y: -43.5%
5Y: -65.2%
¥10.53 ($1.57)
+0.23 (+2.23%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥6.0B ($897.2M)
52W Range8.34-17
Volume8,484,316
Avg Volume10,172,223
Beta0.21
Dividend¥0.02
Analyst Ratings
No analyst coverage
Company Info
CEOYong Bo Song
Employees1,689
SectorHealthcare
IndustryMedical - Specialties
IPO Date2021-05-17
Websiteszyhlo.com
Building 1, Baolong, 2nd Road
Shenzhen, GD 518116
CN
Shenzhen, GD 518116
CN
86 755 2660 1910
About Shenzhen YHLO Biotech Co., Ltd.
Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers chemiluminescence immunoassay analyzer, diabetes solution, automated biochemical analyzer, laboratory automation, tenfly phoenix blot analyzer, VISION Pro ESR analyzer, and VISION ESR analyzer. The company was founded in 2008 and is headquartered in Shenzhen, China.
Latest News
No recent news
Recent Insider Trades
No insider trades found